How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors

… FDA accepted its New Drug Application for zanzalintinib in metastatic … news could lead you to rethink how pessimistic or optimistic those …